Perimenopause vs Menopause vs Postmenopause: Three Stages, One Transition

Most women — and most doctors — use “menopause” as a catch-all term for everything that happens when your periods stop. The bleeding gets weird. You get hot at strange times. Your mood shifts. You stop sleeping through the night. You assume all of this is “menopause” and you’re partially right — but you’re also missing the important differences between the three distinct stages your body moves through.

Perimenopause, menopause, and postmenopause are not the same thing, and your treatment options change depending on which stage you’re in. Menopause itself — the technical definition — lasts exactly one day: the 12-month anniversary of your final menstrual period. Everything before that day is perimenopause. Everything after is postmenopause. The distinction matters because the treatments that work in perimenopause may be different from what you need in postmenopause, and misidentifying your stage leads to mistimed or ineffective treatment.

This article walks through each stage, the symptoms that define it, and what you need to know about treatment timing. For a broader overview of the entire process, read our guide on what is menopause.

Perimenopause: The Long, Confusing Prelude

Perimenopause literally means “around menopause.” It’s the transition period when your ovaries begin to wind down estrogen production but haven’t stopped yet. The process is not linear — some months your estrogen spikes higher than normal, other months it barely registers. Your body becomes a hormonal pinball machine, and the symptoms reflect the chaos, not just the decline.

Perimenopause typically starts in a woman’s mid-to-late 40s, but can begin as early as the mid-30s. The average duration is 4 to 7 years, but a 2025 review published in Nature on perimenopause symptoms in US women noted that the transition can last up to 14 years for some women. The hallmark of early perimenopause is cycle irregularity — your period comes early, late, or not at all. Late perimenopause is defined by 60 or more days between periods. Once you’ve gone 12 months without a period, you’ve officially crossed into the menopause stage.

The symptoms of perimenopause are more numerous and often more intense than what women experience after menopause. A 2025 Flo Health study analyzing data from thousands of international women and presented at The Menopause Society found that perimenopausal women reported higher rates of mood changes, anxiety, brain fog, and joint pain compared to postmenopausal women. The reason is hormonal volatility, not deficiency — your brain is reacting to unpredictable estrogen spikes and drops, not just low estrogen.

One specific detail that surprises most women: FSH (follicle-stimulating hormone) levels in perimenopause are often higher than in postmenopause. Your pituitary gland cranks up FSH production to try to stimulate your aging ovaries to release an egg. The ovaries don’t cooperate, so FSH keeps climbing. A 2024 study in Menopause found that perimenopausal women had average FSH levels of 25 to 40 IU/L, compared to 40 to 60+ IU/L after menopause. But the variability is what matters — FSH can swing from 10 to 100 in a single cycle during perimenopause.

For treatment, the STRAW+10 criteria (Stages of Reproductive Aging Workshop, updated 2012) are the gold standard for staging reproductive aging. The criteria divide the menopausal transition into seven stages based on menstrual cycle patterns and hormone levels. Your gynecologist uses this system — or should — to determine where you are in the transition. If your doctor tells you perimenopause “can’t be diagnosed by a blood test,” they’re only half right. A single FSH reading can’t stage you, but serial FSH along with menstrual history can confirm the transition has started. For the typical age ranges, see our guide on menopause age.

Menopause: The One-Day Milestone

Strictly speaking, menopause is a single point in time — the day you reach the 12-month mark without a period. You can’t know you’ve reached it until you’ve already been in it for a year. That’s not a bureaucratic technicality. It’s a clinical distinction with real implications for diagnosis and treatment.

The average age of natural menopause in the United States is 51 to 52 years, with a normal range of 45 to 55. Premature menopause (before age 40) affects roughly 1% of women. Early menopause (ages 40 to 45) affects about 5%. If you haven’t reached menopause by age 55, you’re in the late menopause category, which is associated with a slightly higher lifetime risk of breast cancer due to longer estrogen exposure — but also better bone density and lower cardiovascular risk.

Menopause itself has no symptoms. The symptoms you associate with “going through menopause” are actually perimenopause symptoms and early postmenopause symptoms. The day you hit the 12-month mark, your body doesn’t do anything special. There’s no hormonal event, no sudden shift. It’s a retrospective diagnosis — a line drawn in the sand by the calendar.

But that line matters for treatment decisions. The 2022 Menopause Society position statement on hormone therapy emphasizes the “window of opportunity” — HRT is safest and most effective when started within ten years of menopause onset and before age 60. The KEEPS 14-year follow-up data from 2024 confirms that HRT started within three years of menopause produces no adverse cardiovascular outcomes. By contrast, starting HRT more than ten years after menopause — in late postmenopause — carries higher risks of thrombosis and stroke. Knowing exactly when you crossed the menopause line gives you and your doctor the time frame for safe HRT initiation.

Postmenopause: The Rest of Your Life

The day after you reach the 12-month mark, you’re in postmenopause. This stage lasts for the remainder of your life. It’s divided into early postmenopause (the first 5 to 8 years) and late postmenopause (everything after). The distinction matters because the rapid bone loss and symptom volatility of early postmenopause differs from the more stable but chronically elevated disease risks of late postmenopause.

Bone density declines fastest in the first 3 to 5 years after menopause. The American College of Cardiology presented findings in April 2024 showing that women’s cardiovascular health declines sharply after menopause — their risk rises quickly to match that of men of the same age. A 2025 study in Frontiers in Endocrinology compared 176 perimenopausal and 120 postmenopausal women with cardiovascular disease and found that postmenopausal women had significantly higher blood pressure, worse lipid profiles, and lower bone density — all linked to the sustained estrogen deficit.

Vasomotor symptoms — hot flashes and night sweats — typically peak during late perimenopause and early postmenopause, then gradually decline over 5 to 10 years. But the MsFLASH trial data showed that a subset of women — roughly 10 to 15% — continue to have moderate to severe hot flashes into their 70s. For these women, the idea that “hot flashes go away on their own” is a myth that delays treatment.

Vaginal and urinary symptoms are a different story. Unlike hot flashes, genitourinary syndrome of menopause (GSM) — vaginal dryness, painful sex, urinary urgency and frequency — tends to get worse over time without treatment. Estrogen receptors in vaginal and urethral tissue depend on circulating estrogen to maintain tissue thickness, elasticity, and lubrication. Without estrogen, the tissue thins, loses elasticity, and becomes prone to irritation and infection. A 2024 Cochrane review of vaginal estrogen treatments confirmed that all forms — rings, tablets, and cream — are equally effective at reversing GSM changes, regardless of how long after menopause treatment starts.

Treatment Implications by Stage

Your treatment options are not the same in perimenopause as they are in postmenopause. Here’s how the stage affects the strategy.

Perimenopause: Hormonal fluctuation makes this the hardest stage to treat. Oral contraceptives can regulate cycles while providing symptom relief. Low-dose HRT (25 mcg estradiol patch) smooths swings without stopping ovulation. Cyclic progesterone (12 days per month) regulates bleeding in women with a uterus.
Early postmenopause (first 5 years): The optimal HRT window. KEEPS and ELITE trial data both support this as the time when estrogen produces the best risk-benefit profile. Bone density responds best here. Hot flash reduction is most dramatic.
Late postmenopause (over 60 or 10+ years past menopause): Starting systemic HRT at this stage carries higher thrombotic and stroke risks. Shift to non-hormonal options for vasomotor symptoms — Veozah, gabapentin, oxybutynin. Vaginal estrogen remains safe. Bisphosphonates replace estrogen’s bone protection.

For a complete breakdown of available treatments by category, visit our guide on menopause treatment options.

How to Know Which Stage You’re In

Track your periods. That’s the single most important tool for staging yourself. Write down the start date and duration of every period. If you’re having cycles less than 21 days apart or more than 35 days apart, you’re likely in perimenopause. If you’ve gone 60 days or more without a period, you’re in late perimenopause. If it’s been 12 months, you’re postmenopausal.

Blood tests can help but shouldn’t be your primary tool. FSH levels above 30 IU/L on two occasions at least 6 weeks apart suggest perimenopause. Levels consistently above 40 IU/L suggest postmenopause. But FSH fluctuates wildly during perimenopause, and a single reading can be misleading. A 2024 review in the Journal of the Endocrine Society recommended against using FSH as a standalone diagnostic tool for staging, because cycle tracking is more accurate for determining where a woman is in the transition.

Anti-Müllerian hormone (AMH) levels can predict proximity to menopause — AMH drops to undetectable levels roughly 5 years before the final menstrual period — but the test is expensive and not routinely covered by insurance for menopause staging. It’s more useful for fertility planning than for determining HRT eligibility.

If you’re already on hormonal contraception, your periods aren’t real periods — they’re withdrawal bleeds from the pill or IUD. In this case, stop the contraception for 2 to 3 months (with your doctor’s supervision) to see if you resume a natural cycle. If you don’t bleed for 12 months after stopping contraception, you were already in menopause. The average woman on the pill tends to be diagnosed with menopause about 2 years later than the average non-user, because the pill masks the transition.

The Bottom Line

Perimenopause, menopause, and postmenopause are not interchangeable terms. Perimenopause is the transition — the years of hormonal chaos, unpredictable cycles, and the most intense symptoms. Menopause is the single day that marks 12 months without a period — a retrospective milestone, not an event you feel. Postmenopause is everything after — the rest of your life, with different health priorities and treatment considerations.

Knowing which stage you’re in determines whether HRT is appropriate, which type of HRT to use, when to start it, and when to stop. It determines whether your symptoms are normal or require further investigation. And it determines the conversations you should be having with your doctor about bone density, cardiovascular risk, and long-term health planning.

Stage isn’t just a label. It’s the roadmap for your treatment decisions. Start your journey at our menopause treatment homepage.